|
2025
|
G/S
|
Pharmaceutical and medicinal preparations and substances; vaccines. |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances;
vaccines. |
|
|
Invention
|
Modified meningococcal fhbp polypeptides.
The present invention provides mutated fHbp polypeptid... |
|
|
G/S
|
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treat... |
|
|
G/S
|
Pharmaceutical preparations and substances; medicinal preparations and substances; vaccines. |
|
|
Invention
|
Modified proteins and methods. The present invention relates to the field of modified nanoparticl... |
|
|
Invention
|
Modified nanoparticle subunits and use thereof. The present invention relates to the field of mod... |
|
|
Invention
|
Hepatitis b immunisation regimen and compositions.
There is provided a method of treating chroni... |
|
|
Invention
|
Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, an... |
|
|
Invention
|
Continuous process for vaccine production.
The present invention relates inter alia to a continu... |
|
2024
|
Invention
|
Influenza virus vaccines. The present invention is inter alia directed to immunogenic composition... |
|
|
Invention
|
Immune system on a chip and uses thereof. Provided herein are multi-immune organ chips, systems c... |
|
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases;... |
|
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tiss... |
|
|
G/S
|
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious disease; ... |
|
|
Invention
|
Enzymatic modification of saponins.
Methods for the enzymatic modification of saponins produced ... |
|
|
Invention
|
Recombinant rna molecules comprising untranslated regions or segments encoding spike protein from... |
|
|
Invention
|
Antigen delivery platforms.
This disclosure provides platforms for delivery of herpes virus prot... |
|
|
G/S
|
Vaccines for human use. |
|
|
Invention
|
Vaccines for neisseria gonorrhoeae.
Methods and compositions for immunizing a human subject agai... |
|
|
Invention
|
Immunogenic compositions.
The invention provides an immunogenic composition comprising OMVs and ... |
|
|
Invention
|
Pre-fusion rsv f antigens.
The invention relates to pre-fusion RSV F protein and polypeptides th... |
|
|
Invention
|
Vaccines for neisseria gonorrhoeae.
A method for immunizing a subject in need thereof against Ne... |
|
|
Invention
|
Modified proteins. Candida albicansCandida albicans') protein. The modified Sap2 protein can be u... |
|
|
Invention
|
Modified proteins. Candida albicansCandida albicans) protein. The modified Als3 protein can be us... |
|
|
Invention
|
Immunogenic compositions and uses thereof.
The present invention is in the field of treating and... |
|
|
Invention
|
Lyophilised composition. The present invention provides lyophilised pharmaceutical compositions a... |
|
|
Invention
|
Immunogenic composition. The present invention relates to immunogenic compositions comprising out... |
|
|
Invention
|
Vaccine. The present invention relates to conjugates comprising polysaccharides comprising 3- deo... |
|
|
Invention
|
Immunogenic composition. S. entericaS.S. Paratyphi A bacterium comprising modified lipid A. |
|
|
Invention
|
Immunogenic composition. The present invention relates to immunogenic compositions comprising ant... |
|
|
Invention
|
Group b streptococcus capsular polysaccharide vaccine and methods of use.
A method of immunizing... |
|
|
Invention
|
Cysteine-substituted rsv-f proteins. inter alia inter alia, an RSV-F protein comprising at least ... |
|
|
Invention
|
Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumon... |
|
|
Invention
|
Modified cytomegalovirus proteins and stabilized complexes.
Described are mutant, human cytomega... |
|
|
Invention
|
Influenza virus vaccines. inter aliainter alia directed to immunogenic compositions for use in th... |
|
|
Invention
|
Hepatitis b immunisation regimen and compositions.
The present invention relates to immunogenic ... |
|
|
Invention
|
Rsv-f-encoding nucleic acids. The present disclosure provides inter alia, a recombinant ribonucle... |
|
|
Invention
|
Rsv-f-encoding nucleic acids. inter alia inter alia, a recombinant nucleic acid encoding a respir... |
|
|
Invention
|
Modified meningococcal fhbp polypeptides.
The inventors have identified residues within variant ... |
|
|
Invention
|
Modified cytomegalovirus proteins and stabilized complexes. Described are mutant human cytomegalo... |
|
|
Invention
|
Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of... |
|
|
Invention
|
Immunisation of large mammals with low doses of rna.
RNA encoding an immunogen is delivered to a... |
|
2023
|
Invention
|
Bacteriophage.
Engineered bacteriophages comprising polynucleotides encoding heterologous protei... |
|
|
Invention
|
Immunogenic compositions.
The present invention provides immunogenic compositions and vaccines c... |
|
|
Invention
|
Modified human cytomegalovirus proteins.
Modified HCMV gB proteins in a pre-fusion conformation,... |
|
2022
|
Invention
|
Method for preparing outer membrane vesicles.
The present invention relates to Shigella outer me... |
|
|
Invention
|
Methods to measure the concentration of aluminium hydroxide in menb vaccines.
The present invent... |
|
|
Invention
|
Plasmid dna purification methods.
This application discloses a method for purifying pDNA, partic... |
|
|
Invention
|
T7 rna polymerase variants for rna synthesis.
The present disclosure provides T7 RNA polymerase ... |
|
|
Invention
|
Ivt rna manufacturing process.
Improved methods for manufacturing a RNA by IVT and compositions ... |
|
|
Invention
|
Shigella vaccine.
The present invention relates to immunogenic compositions and their use in pro... |
|
|
Invention
|
Low-dose lyophilized rna vaccines and methods for preparing and using the same.
Compositions and... |
|
|
Invention
|
Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof.
Composit... |
|
|
Invention
|
Novel influenza antigens.
Recombinant influenza B strain haemagglutinin antigens, polynucleotide... |
|
|
Invention
|
Process for bioconjugate production.
The present invention relates to a process for the producti... |
|
|
Invention
|
Mutated pglb oligosaccharyltransferase enzymes.
The present disclosure provides mutated PglB oli... |
